INTRODUCTION OF HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY (HIPEC) TO THE SURGERY PROGRAM
Keywords:
CHEMOTHERAPY, ABDOMINAL CANCER, HIPEC, CYTOREDUCTIVE SURGERY, peritoneal malignancy, hyperthermia, INTRAPERITONEALAbstract
Heated Intraoperative Intraperitoneal Chemotherapy (HIPEC) offers a chance for extended survival, or cure, to patients facing specific types of invasive abdominal cancer. This article will explore the perioperative facets of implementing a peritoneal malignancy program that includes the HIPEC procedure. In exploring this procedure, experiences will be shared with the intent of optimizing patient care for potential surgical programs and perioperative staff. The examination will illustrate the respective program development areas such as training, budgetary requirements and patient care considerations. Further, the dialogue will investigate patient selection, preoperative preparation and intraoperative considerations. Lastly, the article will reveal the specific shortterm and long-term patient outcomes starting with the immediate postoperative phase.
References
The Quotations Page. (2007).
Quotation Details. Retrieved
February 6, 2010 from
http://www.quotationspage.com/
quote/31217.html
González-Moreno, S., González-
Bayón, L.A., & Ortega-Pérez, G.
(2010). Hyperthermic
intraperitoneal chemotherapy:
Rationale and technique. World
Journal of Gastrointestinal
Oncology, 2(2), 68-75.
Foltz, P., Wavrin, C., & Sticca, R.
(2004). Heated intraoperative
chemotherapy – The challenges of
bringing chemotherapy into
surgery. AORN Journal, 80(6),
-1068.
Sutton, S.W., Yancey, L.W., Chase,
V.A., Hunley, E.K., McCarty, T.M.,
Kuhn, J.A., et al. (2002).
Intraoperative modality of
treatment for peritoneal
carcinomatosis: use of
hyperthermic intraperitoneal
chemoperfusion. Perfusion, 17,
-446.
Langlie-Lesnik. (2008). Appendix
Cancer and Peritoneal Surface
Malignancy. Retrieved November
, 2008, from
http://www.appendixcancer.com/
Peritoneal%20Chemotherapy%20
and%20Intraoperative%20
Peritoneal%20Hyperthermic%20
Chemotherapy.htm
Muehlbauer, P. M., Klapec, K.,
Locklin, J., George, J. L., et al.
(2006). Nursing Implications of
Administering Chemotherapy in
Interventional Radiology or the
Operating Room. Clinical Journal
of Oncology, 10(3), 345-359.
Wright, D. (1998). The Ultimate
Guide to Competency Assessment
in Healthcare (2nd ed.). PESI
Healthcare, LLC.
Jeffries, P. R. (2008). Getting in
S.T.E.P. with simulations: Simulations
take educator preparation. Journal
of Nursing Education, 29(2), 70-73.
Alinier, A. (2007). A typology of
educationally focused medical
simulation tools. Medical Teacher,
(8), 243-250. doi:
1080/01421590701551185
Mohamed, F., & Moran, B.J.
(2009). Morbidity and Mortality
with Cytoreductive Surgery and
Intraperitoneal Chemotherapy: The
importance of a Learning Curve.
The Cancer Journal,15(3), 196-200.
Cotte, E., Passot, G., Mohamed, F.,
Vaudoyer, D., et al. (2009).
Management of Peritoneal
carcinomatosis From Colorectal
cancer: Current State of Practice.
The Cancer Journal, 15(3), 243-249.
White, S. K. (1996). Hyperthermic
intraoperative intraperitoneal
chemotherapy safety considerations.
AORN Journal, 63, 716-724.
Martin, K., Oleszewski, K., &
Muehlbauer, P. (2007).
Intraperitoneal Chemotherapy:
Implications Beyond Ovarian
Cancer. Clinical Journal of
Oncology Nursing, 11(6), 881- 890.
Foundation for Applied Research in
Gastrointestinal Oncology (n.d.).
Hyperthermic Intraperitoneal
Chemotherapy Tutorial. Retrieved
November 2, 2008 from
http://www.surgicaloncology.com/
hiicman.htm
Esquivel, J. (2007). Cytoreductive
Surgery for Peritoneal
Malignancies – Development of
Standards of Care for the
Community. Surgical Oncology
Clinics of North America,16, 653-
Glockzin, G., Schlitt, H.J., & Piso,
P. (2009). Peritoneal carcinomatosis:
patients selection, perioperative
complications and quality of life
related to cytoreductive surgery
and hyperthermic intraperitoneal
chemotherapy. World Journal of
Surgical Oncology, 7(5), doi:
1186/1477-7819-7-5
Tuttle, T.M., Zhang, Y., Greeno,
E., & Knutsen, A. (2006). Toxicity
and Quality of Life after
Cytoreductive Surgery Plus
Hyperthermic Intraperitoneal
Chemotherapy. Annals of Surgical
Oncology, 13(12), 1627-1632. doi:
1245/s10434-006-9186-6
